View this email in your browser
Please join us at ECCMID 2024, where esteemed physicians and infectious disease specialists will share their expertise at our sponsored symposia and Innovation Theater sessions

In between attending our symposia, come and visit our Pfizer booth (A2 and A3)!
The Global Threat of AMR: Understanding the Challenge and Advancing Solutions

The first session in our Innovation Theater series will cover the issues surrounding antimicrobial resistance (AMR). Jennifer Young Maloney and Dr. Jay Purdy will be having a conversation on the urgent need for collaborative solutions to combat AMR and ensure a future with effective antimicrobials. Because time is life.

Saturday 27th April  |  11:00–11:20 CEST  |  Innovation Theater
The clock is ticking – crucial first steps towards early appropriate treatment of MDR Gram-negative bacterial infections

Time is a precious commodity. Get involved in our integrated symposium with our expert faculty that reflect the key members of a multidisciplinary team. Led by Prof. David van Duin (Pfizer-appointed) and Prof. Spyros Pournaras (ESCMID-appointed), we’ll learn more about risk factors and the significance of initial treatment decisions. Followed by a panel discussion.

Saturday 27th April  |  12:15–13:15 CEST  |  Hall P
Multidisciplinary insights for invasive mould disease (IMD) management

Come together to cultivate understanding. The integrated session, chaired by Prof. Patricia Muñoz (Pfizer-appointed) and Prof. Monica Slavin (ESCMID-appointed), will explore the complexities of managing IMD in challenging situations, such as on the hematology unit or patients undergoing solid organ transplant (SOT), across different geographical regions, and how we can collaborate as a multi-disciplinary team.

Saturday 27th April  |  13:30–15:30 CEST  |  Hall P
Challenge Accepted: Innovating AMR Surveillance through Data

Join the second of our two Innovation Theater sessions with Katherine Perez, PharmD, BCIDP, for a deep dive on ATLAS and the value of surveillance data. Could artificial intelligence help to crack the code on multi-drug resistant infections?

Sunday 28th April  |  11:00–11:20 CEST  |  Innovation Theater
How can data prepare us for the rising threat of the MBL-producing Enterobacterales or the management of CAP and cSSTI?

This integrated session, led by Dr. Alex Soriano (Pfizer-appointed) and Prof. Yehuda Carmeli (ESCMID-appointed), will reflect on the evolving epidemiology of metallo-beta-lactamases (MBLs) and their anticipated burden on healthcare systems. Our experts will also review clinical data and real-world evidence on optimized treatment regimens for Gram-positive bacterial infections.

Sunday 28th April  |  16:00–17:30 CEST  |  Hall P
We look forward to seeing you at the upcoming events!

You have received this email as a contact of ESCMID or one of its affiliated societies.
You can unsubscribe here.